Lv01
0 积分 2024-11-22 加入
Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer
4小时前
待确认
Evolution of anti-HER2 therapies for cancer treatment
5小时前
已完结
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
5小时前
已完结
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
6小时前
已完结
Molecular determinants as therapeutic targets in cancer chemotherapy: An update
6小时前
已完结
The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer
1个月前
已完结
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
3个月前
已完结
Application of postoperative adjuvant radiotherapy in limited-stage small cell lung cancer: A systematic review and meta-analysis
4个月前
已完结
皖公网安备34019202002308
